Selected research
Industry Research
Pomalidomide Capsules Industry Research Report 2026
Market perspective
The global Pomalidomide Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pomalidomide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pomalidomide Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pomalidomide Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pomalidomide Capsules include Chia Tai Tianqing Pharmaceutical, Qilu Pharmaceutical, Natco Pharma, Hetero, Dr Reddy’s Laboratories, Bristol Myers Squibb, Apotex, Adalvo and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pomalidomide Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pomalidomide Capsules Market by Company
Chia Tai Tianqing Pharmaceutical
Qilu Pharmaceutical
Natco Pharma
Hetero
Dr Reddy’s Laboratories
Bristol Myers Squibb
Apotex
Adalvo
Abbott Laboratories
Pomalidomide Capsules Segment by Type
1mg per Unit
2mg per Unit
3mg per Unit
4mg per Unit
Pomalidomide Capsules Segment by Application
Kaposi Sarcoma
Multiple Myeloma
Pomalidomide Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pomalidomide Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pomalidomide Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pomalidomide Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pomalidomide Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pomalidomide Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pomalidomide Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1mg per Unit
- 2mg per Unit
- 3mg per Unit
- 4mg per Unit
Applications
- Kaposi Sarcoma
- Multiple Myeloma
Companies covered
- Chia Tai Tianqing Pharmaceutical
- Qilu Pharmaceutical
- Natco Pharma
- Hetero
- Dr Reddy’s Laboratories
- Bristol Myers Squibb
- Apotex
- Adalvo
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pomalidomide Capsules Market Size (2021-2032)
- 2.2.2 Global Pomalidomide Capsules Sales (2021-2032)
- 2.2.3 Global Pomalidomide Capsules Market Average Price (2021-2032)
- 2.3 Pomalidomide Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1mg per Unit
- 2.3.3 2mg per Unit
- 2.3.4 3mg per Unit
- 2.3.5 4mg per Unit
- 2.4 Pomalidomide Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Kaposi Sarcoma
- 2.4.3 Multiple Myeloma
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pomalidomide Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pomalidomide Capsules Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pomalidomide Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Pomalidomide Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Pomalidomide Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pomalidomide Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pomalidomide Capsules, Product Type & Application
- 3.8 Global Manufacturers of Pomalidomide Capsules, Established Date
- 3.9 Global Pomalidomide Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chia Tai Tianqing Pharmaceutical
- 4.1.1 Chia Tai Tianqing Pharmaceutical Company Information
- 4.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
- 4.1.3 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product Portfolio
- 4.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
- 4.2 Qilu Pharmaceutical
- 4.2.1 Qilu Pharmaceutical Company Information
- 4.2.2 Qilu Pharmaceutical Business Overview
- 4.2.3 Qilu Pharmaceutical Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qilu Pharmaceutical Pomalidomide Capsules Product Portfolio
- 4.2.5 Qilu Pharmaceutical Recent Developments
- 4.3 Natco Pharma
- 4.3.1 Natco Pharma Company Information
- 4.3.2 Natco Pharma Business Overview
- 4.3.3 Natco Pharma Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Natco Pharma Pomalidomide Capsules Product Portfolio
- 4.3.5 Natco Pharma Recent Developments
- 4.4 Hetero
- 4.4.1 Hetero Company Information
- 4.4.2 Hetero Business Overview
- 4.4.3 Hetero Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hetero Pomalidomide Capsules Product Portfolio
- 4.4.5 Hetero Recent Developments
- 4.5 Dr Reddy’s Laboratories
- 4.5.1 Dr Reddy’s Laboratories Company Information
- 4.5.2 Dr Reddy’s Laboratories Business Overview
- 4.5.3 Dr Reddy’s Laboratories Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Dr Reddy’s Laboratories Pomalidomide Capsules Product Portfolio
- 4.5.5 Dr Reddy’s Laboratories Recent Developments
- 4.6 Bristol Myers Squibb
- 4.6.1 Bristol Myers Squibb Company Information
- 4.6.2 Bristol Myers Squibb Business Overview
- 4.6.3 Bristol Myers Squibb Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bristol Myers Squibb Pomalidomide Capsules Product Portfolio
- 4.6.5 Bristol Myers Squibb Recent Developments
- 4.7 Apotex
- 4.7.1 Apotex Company Information
- 4.7.2 Apotex Business Overview
- 4.7.3 Apotex Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Apotex Pomalidomide Capsules Product Portfolio
- 4.7.5 Apotex Recent Developments
- 4.8 Adalvo
- 4.8.1 Adalvo Company Information
- 4.8.2 Adalvo Business Overview
- 4.8.3 Adalvo Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Adalvo Pomalidomide Capsules Product Portfolio
- 4.8.5 Adalvo Recent Developments
- 4.9 Abbott Laboratories
- 4.9.1 Abbott Laboratories Company Information
- 4.9.2 Abbott Laboratories Business Overview
- 4.9.3 Abbott Laboratories Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Abbott Laboratories Pomalidomide Capsules Product Portfolio
- 4.9.5 Abbott Laboratories Recent Developments
5 Global Pomalidomide Capsules Market Scenario by Region
- 5.1 Global Pomalidomide Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pomalidomide Capsules Sales by Region: 2021-2032
- 5.2.1 Global Pomalidomide Capsules Sales by Region: 2021-2026
- 5.2.2 Global Pomalidomide Capsules Sales by Region: 2027-2032
- 5.3 Global Pomalidomide Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Pomalidomide Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Pomalidomide Capsules Revenue by Region: 2027-2032
- 5.4 North America Pomalidomide Capsules Market Facts & Figures by Country
- 5.4.1 North America Pomalidomide Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pomalidomide Capsules Sales by Country (2021-2032)
- 5.4.3 North America Pomalidomide Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pomalidomide Capsules Market Facts & Figures by Country
- 5.5.1 Europe Pomalidomide Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pomalidomide Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Pomalidomide Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pomalidomide Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pomalidomide Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pomalidomide Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pomalidomide Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pomalidomide Capsules Market Facts & Figures by Country
- 5.7.1 South America Pomalidomide Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pomalidomide Capsules Sales by Country (2021-2032)
- 5.7.3 South America Pomalidomide Capsules Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pomalidomide Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pomalidomide Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pomalidomide Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pomalidomide Capsules Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pomalidomide Capsules Sales by Type (2021-2032)
- 6.1.1 Global Pomalidomide Capsules Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pomalidomide Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Pomalidomide Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Pomalidomide Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pomalidomide Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Pomalidomide Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pomalidomide Capsules Sales by Application (2021-2032)
- 7.1.1 Global Pomalidomide Capsules Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pomalidomide Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Pomalidomide Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Pomalidomide Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pomalidomide Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Pomalidomide Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pomalidomide Capsules Value Chain Analysis
- 8.1.1 Pomalidomide Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pomalidomide Capsules Production Mode & Process
- 8.2 Pomalidomide Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pomalidomide Capsules Distributors
- 8.2.3 Pomalidomide Capsules Customers
9 Global Pomalidomide Capsules Analyzing Market Dynamics
- 9.1 Pomalidomide Capsules Industry Trends
- 9.2 Pomalidomide Capsules Industry Drivers
- 9.3 Pomalidomide Capsules Industry Opportunities and Challenges
- 9.4 Pomalidomide Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst